安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Technology Melior Pharmaceuticals | Melior Affiliate
Melior Discovery Melior Pharmaceuticals leverages the proprietary technology if its affiliate company, Melior Discovery, to identify new indications for drugs that have existing clinical data in other indications Melior Discovery is a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning
- About Melior Pharmaceuticals | Clinical Stage Diabetes, NASH, Parkinson . . .
About Us Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of de-risked therapies in areas with significant unmet needs Our lead clinical stage candidates are in the areas of diabetes, NASH, Parkinson’s Disease and sleep disorders We leverage the proprietary drug-repositioning technology of our affiliate company, Melior Discovery, to identify new targets
- Melior Pharmaceuticals | Biopharmaceutical Research Development . . .
Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of innovative, de-risked drug candidates in disease areas with significant unmet needs
- Pipeline Melior | Mid-Stage Biopharma Pipeline Therapies
phase 2 ready therapies, mid-stage biopharma pipeline therapies, melior pharmaceuticals pipeline
- Management Team - Melior Pharmaceuticals
Meet the management team of Melior Pharmaceuticals, responsible for business development and investment inquiries
- Tolimidone – Lyn Kinase Activator| Type 2 Diabetes, NASH Therapy Research
Overview: Tolimidone is a novel, clinical stage drug candidate for the treatment of Type 2 Diabetes and Nonalcoholic Steatohepatis (NASH) Tolimidone improves glycemic control by selectively activating the enzyme lyn kinase, which has been shown to modulate the insulin-signaling pathway Tolimidone is the first described specific and direct activator of Lyn kinase that elicits glycemic control
- Contact Melior Pharmaceuticals | Biopharma, Clinical Stage Business . . .
Contact Melior Pharmaceuticals office in Exton, Pennsylvania for business development inquiries regarding clinical stage biopharma therapies
- Melior Announces Research Collaboration with Merck
About Melior Melior Discovery and its sister companies, Melior Pharmaceuticals I, Inc and Melior Pharmaceuticals II, LLC, are leaders in pharmaceutical drug repositioning using the unique theraTRACE® platform comprised of multiplexed in vivo disease models
|
|
|